Inventor
CHARLES A. FLENTGE
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07DHeterocyclic compounds38%
A61KPreparations for medical, dental or toiletry purposes23%
PatentTitleYear
12,351,559Benzoimidazol benzomidazol-1,2-yl amides as Kv7 channel activators202512,286,408KV7 channel activators compositions and methods of use202511,834,418Benzoimidazol-1,2-yl amides as Kv7 channel activators202311,724,990Kv7 channel activators compositions and methods of use202311,261,162KV7 channel activators compositions and methods of use2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2023Patents assigned to KNOPP BIOSCIENCES LLC (2)· patent assignee history
2022–2025Based in US· patent location history
2023–2025Patents assigned to BIOHAVEN THERAPEUTICS LTD (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BIOHAVEN THERAPEUTICS LTD | 4 | 2023–2025 |
| KNOPP BIOSCIENCES LLC | 2 | 2022–2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2022–2025 |